The Gross Margin of Paradigm Biopharmaceuticals Ltd (PAR.AX) is 99.86%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-06-30 | 99.86% |
| 2023-06-30 | 99.78% |
| 2022-06-30 | 98.18% |
| 2021-06-30 | 98.84% |